Literature DB >> 18592155

Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma.

Kai-Zhong Luo1, Toshiyuki Itamoto, Hironobu Amano, Akihiko Oshita, Yuichiro Ushitora, Yoshisato Tanimoto, Hideki Ohdan, Hirotaka Tashiro, Toshimasa Asahara.   

Abstract

BACKGROUND: The purpose of the study was to compare the abilities of the JIS and modified JIS (m-JIS) scores to predict survival after hepatectomy for hepatocellular carcinoma (HCC).
METHODS: Data for patients who underwent hepatectomy for HCC at Hiroshima University Hospital between 1986 and 2006 were included. The overall survival and disease-free survival were calculated by the Kaplan-Meier method, and differences between groups were tested by the log-rank test. The statistics of the Akaike information criterion (AIC) were used to show the more appropriate model.
RESULTS: A total of 626 patients were included (male/female, 468/158; mean age, 63.4+/-9.6 years; Child-Pugh class A/B, 524/102; liver damage grade A/B/C, 356/261/9). Mean survival and disease-free survival were 8.04+/-0.39 and 4.69+/-0.32 years, respectively. There was a significant difference in the overall survival rate between JIS scores 1 and 2, and 2 and 3 (P<0.05), but not between scores 0 and 1, or 3 and 4 (P>0.05). Except between m-JIS scores 0 and 1, there was excellent discriminatory ability in overall survival rate between other consecutive groups. Concerning disease-free survival, a significant difference was found only between JIS scores 1 and 2. However, the disease-free survival rate could be well differentiated between m-JIS scores 1 and 2, and 3 and 4. The m-JIS score had a higher discriminatory ability, indicated by a linear trend analysis, and a higher homogeneity likelihood ratio, and lower AIC statistics, than the original JIS score in predicting both overall and disease-free survival.
CONCLUSIONS: The modified-JIS scoring system using liver damage grade is better than the original JIS scoring system in predicting survival after hepatectomy for HCC in Japan.

Entities:  

Mesh:

Year:  2008        PMID: 18592155     DOI: 10.1007/s00535-008-2164-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  22 in total

1.  Comparison of the grade evaluated by "Liver damage" of Liver Cancer Study Group of Japan and Child-Pugh classification in patients with hepatocellular carcinoma.

Authors:  Katsuhisa Omagari; Kazuo Ohba; Yoshiko Kadokawa; Hiroaki Hazama; Jun-Ichi Masuda; Hideki Kinoshita; Isao Matsuo; Ken Ohnita; Yohei Mizuta; Kenji Hayashida; Shigeru Kohno
Journal:  Hepatol Res       Date:  2006-02-03       Impact factor: 4.288

2.  Indications of partial hepatectomy for transplantable hepatocellular carcinoma with compensated cirrhosis.

Authors:  Toshiyuki Itamoto; Hideki Nakahara; Hirotaka Tashiro; Hideki Ohdan; Hiroshi Hino; Makoto Ochi; Toshimasa Asahara
Journal:  Am J Surg       Date:  2005-02       Impact factor: 2.565

Review 3.  Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Authors:  Masatoshi Kudo; Hobyung Chung; Yukio Osaki
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

4.  Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan.

Authors:  Hidenori Toyoda; Takashi Kumada; Seiki Kiriyama; Yasuhiro Sone; Makoto Tanikawa; Yasuhiro Hisanaga; Akihiro Yamaguchi; Masatoshi Isogai; Yuji Kaneoka; Junji Washizu
Journal:  Am J Gastroenterol       Date:  2005-08       Impact factor: 10.864

5.  A modified Japan Integrated Stage score for prognostic assessment in patients with hepatocellular carcinoma.

Authors:  Iwao Ikai; Kenichi Takayasu; Masao Omata; Kiwamu Okita; Yasuni Nakanuma; Yutaka Matsuyama; Masatoshi Makuuchi; Masamichi Kojiro; Takafumi Ichida; Shigeki Arii; Yoshio Yamaoka
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

6.  Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Authors:  Masatoshi Kudo; Hobyung Chung; Seiji Haji; Yukio Osaki; Hiroko Oka; Toshihito Seki; Hiroshi Kasugai; Yo Sasaki; Takashi Matsunaga
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

7.  Report of the 16th follow-up survey of primary liver cancer.

Authors:  Iwao Ikai; Shigeki Arii; Takafumi Ichida; Kiwamu Okita; Masao Omata; Masamichi Kojiro; Kenichi Takayasu; Yasuni Nakanuma; Masatoshi Makuuchi; Yutaka Matsuyama; Yoshio Yamaoka
Journal:  Hepatol Res       Date:  2005-07-18       Impact factor: 4.288

8.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

9.  Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors.

Authors:  Kun Yan; Min Hua Chen; Wei Yang; Yan Bin Wang; Wen Gao; Chun Yi Hao; Bao Cai Xing; Xin Fu Huang
Journal:  Eur J Radiol       Date:  2007-08-31       Impact factor: 3.528

10.  Report of the 15th follow-up survey of primary liver cancer.

Authors:  Iwao Ikai; Yuji Itai; Kiwamu Okita; Masao Omata; Masamichi Kojiro; Kenichi Kobayashi; Yasuni Nakanuma; Shunji Futagawa; Masatoshi Makuuchi; Yoshio Yamaoka
Journal:  Hepatol Res       Date:  2004-01       Impact factor: 4.288

View more
  4 in total

1.  A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort.

Authors:  Tian Yang; Jin Zhang; Jun-Hua Lu; Li-Qun Yang; Guang-Shun Yang; Meng-Chao Wu; Wei-Feng Yu
Journal:  J Cancer Res Clin Oncol       Date:  2010-07-06       Impact factor: 4.553

2.  Transcatheter arterial infusion chemotherapy with cisplatin-lipiodol suspension in patients with hepatocellular carcinoma.

Authors:  Masafumi Ikeda; Seishi Maeda; Hiroshi Ashihara; Hiroyasu Nagahama; Motohiko Tanaka; Yutaka Sasaki
Journal:  J Gastroenterol       Date:  2009-08-05       Impact factor: 7.527

3.  An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy.

Authors:  Yukio Tokumitsu; Takao Tamesa; Satoshi Matsukuma; Noriaki Hashimoto; Yoshinari Maeda; Yoshihiro Tokuhisa; Kazuhiko Sakamoto; Tomio Ueno; Shoichi Hazama; Hiroyuki Ogihara; Yusuke Fujita; Yoshihiko Hamamoto; Masaaki Oka; Norio Iizuka
Journal:  Int J Oncol       Date:  2014-12-17       Impact factor: 5.650

4.  Interaction between periodontitis and liver diseases.

Authors:  Pengyu Han; Dianxing Sun; Jie Yang
Journal:  Biomed Rep       Date:  2016-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.